Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 2
2006 1
2007 2
2008 2
2009 3
2010 3
2011 2
2012 1
2014 1
2015 2
2016 1
2017 1
2018 1
2019 4
2020 1
2022 1
2023 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension.
Berdahl JP, Sarkisian SR Jr, Ang RE, Doan LV, Kothe AC, Usner DW, Katz LJ, Navratil T; Travoprost Intraocular Implant Study Group. Berdahl JP, et al. Among authors: usner dw. Drugs. 2024 Jan;84(1):83-97. doi: 10.1007/s40265-023-01973-7. Epub 2023 Dec 7. Drugs. 2024. PMID: 38060092 Free PMC article. Clinical Trial.
A Randomized, Controlled Comparison of NCX 470 (0.021%, 0.042%, and 0.065%) and Latanoprost 0.005% in Patients With Open-angle Glaucoma or Ocular Hypertension: The Dolomites Study.
Walters TR, Kothe AC, Boyer JL, Usner DW, Lopez K, Duquesroix B, Fechtner RD, Navratil T. Walters TR, et al. Among authors: usner dw. J Glaucoma. 2022 Jun 1;31(6):382-391. doi: 10.1097/IJG.0000000000002030. Epub 2022 Apr 6. J Glaucoma. 2022. PMID: 35394456 Free PMC article. Clinical Trial.
Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2).
Kahook MY, Serle JB, Mah FS, Kim T, Raizman MB, Heah T, Ramirez-Davis N, Kopczynski CC, Usner DW, Novack GD; ROCKET-2 Study Group. Kahook MY, et al. Among authors: usner dw. Am J Ophthalmol. 2019 Apr;200:130-137. doi: 10.1016/j.ajo.2019.01.003. Epub 2019 Jan 15. Am J Ophthalmol. 2019. PMID: 30653957 Free article. Clinical Trial.
Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2).
Serle JB, Katz LJ, McLaurin E, Heah T, Ramirez-Davis N, Usner DW, Novack GD, Kopczynski CC; ROCKET-1 and ROCKET-2 Study Groups. Serle JB, et al. Among authors: usner dw. Am J Ophthalmol. 2018 Feb;186:116-127. doi: 10.1016/j.ajo.2017.11.019. Epub 2017 Dec 1. Am J Ophthalmol. 2018. PMID: 29199013 Free article. Clinical Trial.
The parachute must be properly folded ..
Donfield SM, Shapiro AD, Gomperts ED, Lynn HS, Usner DW. Donfield SM, et al. Among authors: usner dw. J Thromb Haemost. 2007 Mar;5(3):646-7. doi: 10.1111/j.1538-7836.2007.02315.x. Epub 2006 Nov 9. J Thromb Haemost. 2007. PMID: 17092299 Free article. No abstract available.
28 results